{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T10:30:42Z","timestamp":1768732242098,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1124\/dmd.105.008706","type":"journal-article","created":{"date-parts":[[2006,4,13]],"date-time":"2006-04-13T00:45:53Z","timestamp":1144889153000},"page":"1122-1127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["QUANTITATIVE DETERMINATION OF ARISTOLOCHIC ACID-DERIVED DNA ADDUCTS IN RATS USING 32P-POSTLABELING\/POLYACRYLAMIDE GEL ELECTROPHORESIS ANALYSIS"],"prefix":"10.1016","volume":"34","author":[{"given":"Huan","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radha R.","family":"Bonala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur P.","family":"Grollman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Shibutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.105.008706_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/mutage\/17.4.265","article-title":"Aristolochic acid as a probable human cancer hazard in herbal remedies: a review.","volume":"17","author":"Arlt","year":"2002","journal-title":"Mutagenesis"},{"key":"10.1124\/dmd.105.008706_bib2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/carcin\/18.5.1063","article-title":"32P-Post-labeling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy.","volume":"18","author":"Bieler","year":"1997","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.105.008706_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200326010-00004","article-title":"Aristolochic acid and \u2018Chinese herbs nephropathy\u2019: a review of the evidence to date.","volume":"26","author":"Cosyns","year":"2003","journal-title":"Drug Saf"},{"key":"10.1124\/dmd.105.008706_bib4","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s002040050568","article-title":"Chinese herbs nephropathy-associated slimming regimen induces tumours in the forestomach but no interstitial nephropathy in rats.","volume":"72","author":"Cosyns","year":"1998","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.105.008706_bib5","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0272-6386(99)70136-8","article-title":"Urothelial lesions in Chinese-herb nephropathy.","volume":"33","author":"Cosyns","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/dmd.105.008706_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1681\/ASN.V132431","article-title":"Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats.","volume":"13","author":"Debelle","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/dmd.105.008706_bib7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0272-6386(12)80178-8","article-title":"Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs.","volume":"24","author":"Depierreux","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/dmd.105.008706_bib8","series-title":"Horse Poisoning with Aristolochia clematitis (in Croatian)","first-page":"3","author":"Dumi\u0107","year":"1954"},{"key":"10.1124\/dmd.105.008706_bib9","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/carcin\/13.10.1835","article-title":"Detection and quantitation of dG-AA I and dA-AA I adducts by 32P-postlabeling methods in urothelium and exfoliated cells in urine of rats treated with aristolochic acid I.","volume":"13","author":"Fernando","year":"1992","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.105.008706_bib10","first-page":"167","article-title":"Formation and persistence of specific purine DNA adducts by 32P-postlabeling in target and non-target organs of rats treated with aristolochic acid I.","volume":"124","author":"Fernando","year":"1993","journal-title":"IARC Sci Pub"},{"key":"10.1124\/dmd.105.008706_bib11","series-title":"Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene, volume 82","first-page":"69","year":"2002"},{"key":"10.1124\/dmd.105.008706_bib12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3109\/00498258709044197","article-title":"Studies on the metabolism of aristolochic acids I and II.","volume":"17","author":"Krumbiegel","year":"1987","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.105.008706_bib13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1039\/b303648k","article-title":"Naturally occurring aristolactams, aristolochic acids and diaxoaporphines and their biological activities.","volume":"20","author":"Kumar","year":"2003","journal-title":"Nat Prod Rep"},{"key":"10.1124\/dmd.105.008706_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1440-1797.2004.00252.x","article-title":"Aristolochic acid nephropathy: what we know and what we have to do.","volume":"9","author":"Li","year":"2004","journal-title":"Nephrology (Carlton)"},{"key":"10.1124\/dmd.105.008706_bib15","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1053\/j.ajkd.2003.11.024","article-title":"DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy.","volume":"43","author":"Lord","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/dmd.105.008706_bib16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/BF00295084","article-title":"Acute toxicity of aristolochic acid in rodents.","volume":"59","author":"Mengs","year":"1987","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.105.008706_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00302751","article-title":"The carcinogeneic action of aristolochic acid in rats.","volume":"51","author":"Mengs","year":"1982","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.105.008706_bib18","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJM200006083422301","article-title":"Urothelial carcinoma associated with the use of a Chinese herb (aristolochia fangchi).","volume":"342","author":"Nortier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.105.008706_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/carcin\/11.2.313","article-title":"Aristolochic acid binds covalently to the exocyclic amino group of purine nucleotides in DNA.","volume":"11","author":"Pfau","year":"1990","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.105.008706_bib20","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/carcin\/11.9.1627","article-title":"32P-Postlabelling analysis of the DNA adducts formed by aristolochic acid I and II.","volume":"11","author":"Pfau","year":"1990","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.105.008706_bib21","first-page":"282","article-title":"Ueber das Aristolochin, einen giftigen Bestandheil der Aristolochia-Arten.","author":"Pohl","year":"1892","journal-title":"Arch Exp Path Pharm"},{"key":"10.1124\/dmd.105.008706_bib22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/carcin\/21.3.353","article-title":"Carcinogen macromolecular adducts and their measurement.","volume":"21","author":"Poirer","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.105.008706_bib23","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1093\/carcin\/7.9.1543","article-title":"Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.","volume":"7","author":"Reddy","year":"1986","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.105.008706_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1211\/0022357023051","article-title":"Acute nephrotoxicity of aristolochic acids in mice.","volume":"56","author":"Sato","year":"2004","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.105.008706_bib25","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/carcin\/18.5.1055","article-title":"Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidases.","volume":"18","author":"Schmeiser","year":"1997","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.105.008706_bib26","first-page":"5464","article-title":"Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues.","volume":"50","author":"Schmeiser","year":"1990","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.105.008706_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0304-3835(91)90178-K","article-title":"Activating mutations at codon 61 of the c-Ha-ras gene in thin-tissue sections of tumors induced by aristolochic acid in rats and mice.","volume":"59","author":"Schmeiser","year":"1991","journal-title":"Cancer Lett"},{"key":"10.1124\/dmd.105.008706_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/carcin\/9.2.297","article-title":"DNA adduct formation of aristolochic acid I and II in vitro and in vivo.","volume":"9","author":"Schmeiser","year":"1988","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.105.008706_bib29","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/carcin\/15.6.1187","article-title":"Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures.","volume":"15","author":"Stiborova","year":"1994","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.105.008706_bib30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0940-2993(99)80033-5","article-title":"Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy.","volume":"51","author":"Stiborova","year":"1999","journal-title":"Exp Toxicol Pathol"},{"key":"10.1124\/dmd.105.008706_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ijc.20564","article-title":"Human hepatic and renal microsomes, cytochromes P450 1A1\/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer.","volume":"113","author":"Stiborova","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1124\/dmd.105.008706_bib32","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/carcin\/bgg119","article-title":"Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase.","volume":"24","author":"Stiborova","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.105.008706_bib33","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/carcin\/23.4.617","article-title":"Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy.","volume":"23","author":"Stiborova","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1124\/dmd.105.008706_bib34","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/tx010059z","article-title":"Human cytochrome P450 enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by CYP1A1 and CYP1A2.","volume":"14","author":"Stiborova","year":"2001","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.105.008706_bib35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1021\/tx010083c","article-title":"32P-Postlabeling\/polyacrylamide gel electrophoresis analysis: application to the detection of DNA adducts.","volume":"15","author":"Terashima","year":"2002","journal-title":"Chem Res Toxicol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624035396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624035396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.105.008706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:08:26Z","timestamp":1739902106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624035396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0090955624035396"],"URL":"https:\/\/doi.org\/10.1124\/dmd.105.008706","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"QUANTITATIVE DETERMINATION OF ARISTOLOCHIC ACID-DERIVED DNA ADDUCTS IN RATS USING 32P-POSTLABELING\/POLYACRYLAMIDE GEL ELECTROPHORESIS ANALYSIS","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.105.008706","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}